Miami, Florida
CNS clinical trials in Miami, FL
82 CNS studies are recruiting participants at sites in Miami as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Miami at a glance
- 82 studies are recruiting at a site in Miami.
- By phase: Phase 1/2 (1), Phase 2 (16), Phase 2/3 (1), Phase 3 (33), Phase 4 (7), No phase (10), Observational (14). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (67), university, hospital or other (14), government (1).
- By research area: Depression (27), Parkinson's Disease (15), Epilepsy (11), Migraine (10), Schizophrenia (10), Multiple Sclerosis (5), Bipolar Disorder (3), ADHD (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Miami
Basic details from each study's public record (the 30 most recently updated of 82). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Avantis Clinical Research
- Registry record
- NCT07226661 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT06748222 · updated
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Miami Jewish Health System · Premier Clinical Research Institute
- Registry record
- NCT05850689 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Care Research Center Inc · Envision Trials LLC · HealthMed Clinical Center Inc
- Registry record
- NCT06372964 · updated
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Nuovida Research Center
- Registry record
- NCT06559306 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study sites
- Nuovida Research Center · Pharmax Research Clinic Inc
- Registry record
- NCT07573176 · updated
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Pharmax Research Clinic Inc
- Registry record
- NCT07716098 · updated
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Diverse Clinical Research · Quantix Research - Miami - Southwest 72nd Street
- Registry record
- NCT07775300 · updated
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06966401 · updated
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Registry record
- NCT07621237 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Miami, FL on ClinicalTrials.gov.
Schizophrenia studies recruiting in Miami
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Blue Medical Research · Care Research Center Inc · Columbus Clinical Services LLC
- Registry record
- NCT06229210 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study sites
- Allied Biomedical Research Institute (ABRI), Inc · South Florida Research Phase I-IV · Sunshine Medical Solution
- Registry record
- NCT06540833 · updated
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study sites
- Banyan Behavioal Care Program - CSU · BioResearch Partner - Miami
- Registry record
- NCT07379827 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Miami, FL on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Miami
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- LCC Medical Research Institute
- Registry record
- NCT06951711 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Miami, FL on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Miami
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- University of Miami Hospital
- Registry record
- NCT02071134 · updated
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Observational
- All ages
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- University of Miami Hospital
- Registry record
- NCT03664609 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214)
- Registry record
- NCT06623422 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Baptist Hospital of Miami
- Registry record
- NCT07174310 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- University of Miami Health System - Neurology
- Registry record
- NCT06944522 · updated
A Study of Buntanetap in Participants With PD
- Phase 2/3
- Ages 40 to 85
- All sexes
- Sponsor
- Annovis Bio Inc.
- Study site
- Professional Research Center
- Registry record
- NCT07284784 · updated
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Phase 2
- Ages 30 to 80
- All sexes
- Sponsor
- Appello Pharmaceuticals, Inc.
- Study site
- University of Miami (Site #220)
- Registry record
- NCT07432958 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Miami, FL on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Miami
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Miami, FL on ClinicalTrials.gov.
Epilepsy studies recruiting in Miami
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Miami VA Healthcare System, Miami, FL
- Registry record
- NCT04419272 · updated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Registry record
- NCT07594119 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Serenity Research Center, LLC
- Registry record
- NCT05667142 · updated
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Study site
- University of Miami
- Registry record
- NCT05135091 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Miami, FL on ClinicalTrials.gov.
Migraine studies recruiting in Miami
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study sites
- Apple Med Research · University of Miami
- Registry record
- NCT06972056 · updated
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study sites
- Apple Medical Research Group, Inc · Blessed Healthcase & Research · Florida Research Center, Inc.
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- AppleMedical Research Group, LLC
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Miami, FL on ClinicalTrials.gov.
Ask about studies near Miami
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
225 studies recruiting across 72 cities.
Tampa
70 studies recruiting.
Orlando
57 studies recruiting.
Jacksonville
39 studies recruiting.
Hollywood
33 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections